Articles
-
1 month ago |
preprints.org | GAURAV KUMAR |Priyanka Chaudhary |Apar Kishor Ganti |Jungyoon Kim
Choose an area of interest and we will send you notifications of new preprints at your preferred frequency.
-
Dec 5, 2024 |
cancernetwork.com | Robin R. High |Apar Kishor Ganti |Alissa Marr |Clayton K. Oakley |Amulya Yellala |Sunil Tulpule
December 5, 2024By OncologyONCOLOGY Vol 38, Issue 12Pages: 462-468These data support less restrictive clinical trial eligibility criteria for those with metastatic NSCLC. This is especially true regarding both targeted therapy and immunotherapy treatment regimens. AbstractIntroduction: There are limited data available regarding patient outcomes in those who would have been ineligible to receive therapy based on the original clinical trial eligibility criteria.
-
Jul 5, 2023 |
mdedge.com | Apar Kishor Ganti
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 259
- Tweets
- 1K
- DMs Open
- No
RT @FIDE_chess: 🇮🇳 Gukesh D is the YOUNGEST WORLD CHAMPION in history! 🔥 👏 https://t.co/MYShXB5M62
Quality of life outcomes in patients participating in the CALGB 30610 trial (CALGB 70702): Alliance - Ganti - Cancer - Wiley Online Library https://t.co/Y6yXaxQI4A
Quality of life outcomes in patients participating in the CALGB 30610 trial (CALGB 70702): Alliance - Ganti - Cancer - Wiley Online Library https://t.co/Y6yXaxQI4A